Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Insulin-like growth factor binding protein 2 (IGFBP-2) is a member of the IGFBP family that binds insulin-like growth factors I and II (IGF-I and IGF-II) with high affinity, regulating their bioavailability and activity. It can also influence cellular processes independently from its interaction with insulin-like growth factors. Dysregulation implicated in cancer biology.
Modulates bioavailability and activity of IGF-I and IGF-II; IGF-independent actions modulating gene expression related to proliferation, adhesion/migration, apoptosis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Insulin-like Growth Factor Binding Protein II (IGFBP-2).